The field of cancer immunology and immunotherapy is witnessing rapid advances as researchers strive to overcome persistent challenges related to immune ...

A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT, an immune checkpoint receptor targeted by cancer immunotherapy drugs, triggers ...

Despite the success of antiretroviral therapy (ART) in controlling HIV replication, a definitive cure remains elusive due to ...